m-Trifluoromethyl-diphenyldiselenide as a pharmacological tool to treat preference symptoms related to AMPH-induced dependence in rats

Amphetamine (AMPH) abuse is a world concern and a serious public health problem. Repeated administration of high doses of AMPH induces neuropsychiatric consequences, including addiction, reward and psychosis, whose pharmacological treatment has shown limited effectiveness. The m-trifluoromethyl-diphenyldiselenide [(m-CF3-PhSe)(2)] has been documented as a promising pharmacological agent in different animal models related to oxidative damage. In this study, we examined the influence of (m-CF3-PhSe)(2) on withdrawal following re-exposure to AMPH. Wistar rats received d, l-AMPH or saline in the conditioned place preference (CPP) paradigm for 8 days. Then, half of each initial (AMPH or saline) experimental group was treated with (m-CF3-PhSe)(2) or vehicle, resulting in four final groups: i) Saline/vehicle; ii) (m-CF3-PhSe)(2)/saline; iii) AMPH/vehicle; and iv) AMPH/(m-CF3-PhSe)(2). After fourteen days of (m-CF3-PhSe)(2) treatment, animals were re-exposed to AMPH or vehicle in the CPP paradigm for three more days in order to assess drug re-conditioning and memory/locomotor activity, performed 24 h after AMPH re-exposure in the CPP and the Y maze, respectively. Subsequently, ex-vivo assays were carried out in samples of the prefrontal cortex (PFC) of the animals. The (m-CF3-PhSe)(2) treatment was able to prevent AMPH-induced re-conditioning symptoms in rats. Behavioral observations in the Y maze task showed no significant changes. AMPH exposure was able to increase 5-HT uptake as well as oxidative damage in the PFC, whereas (m-CF3-PhSe)(2) treatment exerted a preventative effect against these alterations. The current findings suggest that (m-CF3-PhSe)(2) might be considered a promising therapeutic tool for AMPH-induced addiction. (C) 2015 Elsevier Inc. All rights reserved.